Demand for remote clinical management explodes due to coronavirus
CluePoints sees demand on services supporting remote clinical trials management ‘dramatically’ increase amid the ongoing coronavirus pandemic.
Archives for March 19, 2020
FDA issues coronavirus guidance for clinical trials
The document offers pointers for the industry, investigators and institutional review boards operating trials in the face of the coronavirus pandemic.
Oracle Health launches decentralized trial survey
The company is seeking industry insights on the use of remote studies and decentralized clinical trial technology.
ViiV Healthcare, UNC extend HIV partnership
Funding has been extended for the public-private collaboration, which unites academic and pharma researchers on discovering HIV treatments.
FDA halts domestic inspections, calls for industry to ‘own’ quality
The US FDA announces that it will no longer be able to carry out domestic facility inspections due to the risk posed by COVID-19.
FDA approves migraine drug formulated for fast dispersion
Biohaven’s drug for acute treatment of migraine, manufactured using Catalent’s Zydis technology for orally disintegrating tablets, receives approval from the US FDA.